Influenza Diagnostics Market by Test type (Traditional (Rapid Influenza Detection Test, Viral Culture, DFA, Serology Test), Molecular (RT-PCR, NASBA, LAMP, SAMBA)), End user (Hospital, Clinic, Reference lab, POC, Home Care Agency) - Global Forecast to 2021

Publisher Name :
Date: 23-Feb-2017
No. of pages: 127
Inquire Before Buying

The global influenza diagnostics market is expected to reach USD 767.4 million by 2021 from USD 508.0million in 2016, at a CAGR of 8.6% from 2016 to 2021. On the basis of test type, the market is segmented into traditional and molecular diagnostic tests. The traditional diagnostic tests segment is further categorized into rapid influenza detection tests (RIDT), viral culture, direct fluorescent antibody (DFA) tests, and serological assays. In 2016, the RIDT segment is expected to account for the largest share of the traditional tests market owing to factors such as its user-friendliness, rapid generation of results, and easy interpretability. The molecular diagnostic tests segment is further divided into RT-PCR, nucleic acid sequence-based amplification (NASBA) tests, loop-mediated isothermal amplification-based assays (LAMP), and simple amplification-based assays (SAMBA).In 2016, the RT-PCR segment is expected to hold the largest share of the molecular diagnostic tests market due to its ability to detect and distinguish between influenza A and B viruses with high specificity.

On the basis of end user, the influenza diagnostics market is segmented into hospitals/clinical laboratories, reference laboratories, and other end users (point-of-care testing, home health agencies, and nursing homes). The hospitals/clinical laboratories end-user segment is expected to dominate the influenza diagnostics market in 2016. The large share of this segment can be attributed to the fact that most influenza disease diagnostic tests are carried out in hospitals and clinical laboratories, as these tests are highly complex in nature and require the use of specialized instruments.

On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2016, the European region is expected to account for the largest share of the market due to the rapidly increasing prevalence of influenza and rise in aging population in Europe.

The increasing prevalence of influenza, growth in research funding for influenza diagnostics, and rising demand for rapid and effective disease diagnosis and treatment are the key factors driving the growth of the global influenza diagnostics market.

Research Coverage:

This report studies the influenza diagnostics market based on test type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends, future prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:


  • Product Development/Innovation: Product portfolios of the top players in the influenza diagnostics market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market

  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the influenza diagnostics market

  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various influenza diagnostic tests across geographies

  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the influenza diagnostics market.

Influenza Diagnostics Market by Test type (Traditional (Rapid Influenza Detection Test, Viral Culture, DFA, Serology Test), Molecular (RT-PCR, NASBA, LAMP, SAMBA)), End user (Hospital, Clinic, Reference lab, POC, Home Care Agency) - Global Forecast to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered in the Report
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Ranking Analysis
2.3 Market Breakdown and Data Triangulation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Conclusion

4 Premium Insights
4.1 Influenza Diagnostics: Market Overview
4.2 Geographic Analysis: Traditional Diagnostic Tests Market, By Type (2016)
4.3 Molecular Diagnostic Tests Market Size, By Type, 2016 vs 2021 (USD Million)
4.4 Life Cycle Analysis, By Region (2016)

5 Market Overview
5.1 Introduction
5.2 Drivers
5.2.1 Increasing Prevalence of Influenza
5.2.2 Growth in Research Funding for Influenza Diagnostics
5.2.3 Rising Demand for Faster Diagnosis and Control of Influenza
5.3 Restraints
5.3.1 Variability in Sensitivity and Specificity Among Influenza Diagnostic Tests
5.3.2 Stringent Regulatory Framework
5.3.3 Rising Healthcare Costs Limiting the Usage of Novel Influenza Diagnostic Techniques
5.4 Opportunities
5.4.1 Advancements in Genomic and Proteomic Technologies
5.4.2 Significant Growth Prospects in Developing Countries
5.5 Challenge
5.5.1 Dearth of Skilled Personnel to Handle Advanced Influenza Diagnostic Tools
5.6 Regulatory Framework
5.6.1 North America
5.6.2 Europe
5.6.3 Asia-Pacific
5.6.3.1 India
5.6.3.2 China
5.6.3.3 Australia

6 Influenza Diagnostics Market, By Test Type
6.1 Introduction
6.2 Traditional Diagnostic Tests
6.2.1 Rapid Influenza Detection Tests (RIDT)
6.2.2 Viral Culture
6.2.3 Direct Fluorescent Antibody (DFA) Tests
6.2.4 Serological Assays
6.3 Molecular Diagnostic Tests
6.3.1 RT-PCR
6.3.2 Nucleic Acid Sequence-Based Amplification (NASBA) Tests
6.3.3 Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
6.3.4 Simple Amplification-Based Assays (SAMBA)
6.3.5 Other Molecular Diagnostic Tests

7 Influenza Diagnostics Market, By End User
7.1 Introduction
7.2 Hospitals/Clinical Laboratories
7.3 Reference Laboratories
7.4 Other End Users

8 Influenza Diagnostics Market, By Region
8.1 Introduction
8.2 Pest Analysis
8.2.1 Political Factors
8.2.2 Economic Factors
8.2.3 Sociocultural Factors
8.2.4 Technological Factors
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 Rest of Europe
8.4 North America
8.4.1 U.S.
8.4.2 Canada
8.5 Asia-Pacific
8.6 Rest of the World (RoW)

9 Competitive Landscape
9.1 Overview
9.2 Leading Players in the Market
9.3 Competitive Situation and Trends
9.3.1 Product Launches and Approvals
9.3.2 Acquisitions
9.3.3 Expansions
9.3.4 Collaborations and Agreements

10 Company Profiles
10.1 Introduction
(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*
10.2 F. Hoffmann-La Roche AG
10.3 Becton, Dickinson and Company
10.4 Thermo Fisher Scientific Inc.
10.5 Alere Inc.
10.6 Diasorin S.P.A.
10.7 Quidel Corporation
10.8 Meridian Bioscience, Inc.
10.9 Analytik Jena AG (A Subsidiary of Endress+Hauser AG)
10.10 Luminex Corporation
10.11 SA Scientific, Ltd.

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured In Case Of Unlisted Companies.

11 Appendix
11.1 Insights of Industry Experts
11.2 Discussion Guide
11.3 Other Developments
11.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.5 Introducing RT: Real-Time Market Intelligence
11.6 Available Customizations
11.7 Related Reports
11.8 Author Details

List of Tables

Table 1 Global Influenza Diagnostics Market Summary
Table 2 Market Size, By Test Type, 2014–2021 (USD Million)
Table 3 Influenza Diagnostics Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 4 Market Size for Traditional Diagnostic Tests, By Region, 2014–2021 (USD Million)
Table 5 North America: Market Size for Traditional Diagnostic Tests, By Country, 2014–2021 (USD Million)
Table 6 Europe: Market Size for Traditional Diagnostic Tests, By Country, 2014–2021 (USD Million)
Table 7 Influenza Diagnostics Market Size for RIDT, By Region, 2014–2021 (USD Million)
Table 8 North America: Market Size for RIDT, By Country, 2014–2021 (USD Million)
Table 9 Europe: Market Size for RIDT, By Country, 2014–2021 (USD Million)
Table 10 Influenza Diagnostics Market Size for Viral Culture, By Region, 2014–2021 (USD Million)
Table 11 North America: Market Size for Viral Culture, By Country, 2014–2021 (USD Million)
Table 12 Europe: Influenza Diagnostics Market Size for Viral Culture, By Country, 2014–2021 (USD Million)
Table 13 Market Size for DFA Tests, By Region, 2014–2021 (USD Million)
Table 14 North America: Influenza Diagnostics Market Size for DFA Tests, By Country, 2014–2021 (USD Million)
Table 15 Europe: Market Size for DFA Tests, By Country, 2014–2021 (USD Million)
Table 16 Influenza Diagnostics Market Size for Serological Assays, By Region, 2014–2021 (USD Million)
Table 17 North America: Market Size for Serological Assays, By Country, 2014–2021 (USD Million)
Table 18 Europe: Influenza Diagnostics Market Size for Serological Assays, By Country, 2014–2021 (USD Million)
Table 19 Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 20 Influenza Diagnostics Market Size for Molecular Tests, By Region, 2014–2021 (USD Million)
Table 21 North America: Market Size for Molecular Tests, By Country, 2014–2021 (USD Million)
Table 22 Europe: Influenza Diagnostics Market Size for Molecular Tests, By Country, 2014–2021 (USD Million)
Table 23 Market Size for RT-PCR, By Region, 2014–2021 (USD Million)
Table 24 North America: Influenza Diagnostics Market Size for RT-PCR, By Country, 2014–2021 (USD Million)
Table 25 Europe: Market Size for RT-PCR, By Country, 2014–2021 (USD Million)
Table 26 Influenza Diagnostics Market Size for NASBA, By Region, 2014–2021 (USD Million)
Table 27 North America: Market Size for NASBA, By Country, 2014–2021 (USD Million)
Table 28 Europe: Influenza Diagnostics Market Size for NASBA, By Country, 2014–2021 (USD Million)
Table 29 Market Size for LAMP, By Region, 2014–2021 (USD Million)
Table 30 North America: Influenza Diagnostics Market Size for LAMP, By Country, 2014–2021 (USD Million)
Table 31 Europe: Market Size for LAMP, By Country, 2014–2021 (USD Million)
Table 32 Influenza Diagnostics Market Size for SAMBA, By Region, 2014–2021 (USD Million)
Table 33 North America: Market Size for SAMBA, By Country, 2014–2021 (USD Million)
Table 34 Europe: Influenza Diagnostics Market Size for SAMBA, By Country, 2014–2021 (USD Million)
Table 35 Market Size for Other Molecular Diagnostic Tests, By Region, 2014–2021 (USD Million)
Table 36 North America: Influenza Diagnostics Market Size for Other Molecular Diagnostic Tests, By Country, 2014–2021 (USD Million)
Table 37 Europe: Influenza Diagnostics Market Size for Other Molecular Diagnostic Tests, By Country, 2014–2021 (USD Million)
Table 38 Influenza Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 39 Market Size for Hospitals/Clinical Laboratories, By Region, 2014–2021 (USD Million)
Table 40 North America: Market Size for Hospitals/Clinical Laboratories, By Country, 2014–2021 (USD Million)
Table 41 Europe: Market Size for Hospitals/Clinical Laboratories, By Country, 2014–2021 (USD Million)
Table 42 Market Size for Reference Laboratories, By Region, 2014–2021 (USD Million)
Table 43 North America: Influenza Diagnostics Market Size for Reference Laboratories, By Country, 2014–2021 (USD Million)
Table 44 Europe: Influenza Diagnostics Market Size for Reference Laboratories, By Country, 2014–2021 (USD Million)
Table 45 Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 46 North America: Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 47 Europe: Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 48 Global Influenza Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 49 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 50 Europe: Influenza Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 51 Europe: Market Size, By Test Type, 2014–2021 (USD Million)
Table 52 Europe: Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 53 Europe: Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 54 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 55 Germany: Market Size, By Test Type, 2014–2021 (USD Million)
Table 56 Germany: Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 57 Germany: Influenza Diagnostics Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 58 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 59 U.K.: Market Size, By Test Type, 2014–2021 (USD Million)
Table 60 U.K.: Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 61 U.K.: Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 62 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 63 RoE: Market Size, By Test Type, 2014–2021 (USD Billion)
Table 64 RoE: Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 65 RoE: Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 66 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 67 North America: Market Size, By Test Type, 2014–2021 (USD Million)
Table 68 North America: Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 69 North America: Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 70 North America: Influenza Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 71 U.S.: Market Size, By Test Type, 2014–2021 (USD Million)
Table 72 U.S.: Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 73 U.S.: Influenza Diagnostics Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 74 U.S.: Influenza Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 75 Canada: Market Size, By Test Type, 2014–2021 (USD Million)
Table 76 Canada: Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 77 Canada: Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 78 Canada: Influenza Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 79 APAC: Market Size, By Test Type, 2014–2021 (USD Billion)
Table 80 APAC: Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 81 APAC: Influenza Diagnostics Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 82 APAC: Market Size, By End User, 2014–2021 (USD Million)
Table 83 RoW: Influenza Diagnostics Market Size, By Test Type, 2014–2021 (USD Million)
Table 84 RoW: Market Size for Traditional Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 85 RoW: Influenza Diagnostics Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 86 RoW: Influenza Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 87 Rank of Companies in the Influenza Diagnostics Market, 2015
Table 88 Product Launches and Approvals, 2014–2016
Table 89 Acquisitions, 2014–2016
Table 90 Expansions, 2014–2016
Table 91 Collaborations and Agreements, 2014–2016

List of Figures

Figure 1 Research Design
Figure 2 Market Size Estimation Methodology: Bottom-Up Approach
Figure 3 Market Size Estimation Methodology: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Influenza Diagnostics Market Size, By Test Type, 2016 vs 2021 (USD Million)
Figure 7 Traditional Diagnostic Tests Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 8 Molecular Diagnostic Tests Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 9 Influenza Diagnostics Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 10 Geographical Snapshot of the Influenza Diagnostics Market
Figure 11 Rising Prevalence of Influenza Across the Globe to Drive the Influenza Diagnostics Market
Figure 12 Rapid Influenza Detection Tests to Command the Largest Market Share in 2016
Figure 13 RT-PCR to Register the Highest Growth in the Forecast Period
Figure 14 Asia-Pacific Presents Lucrative Growth Opportunities for Players in the Global Influenza Diagnostics Market
Figure 15 Influenza Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 RIDT to Dominate the Traditional Diagnostic Tests Market in 2016
Figure 17 RT-PCR to Dominate the Molecular Diagnostic Tests Market in 2016
Figure 18 Hospitals/Clinical Laboratories to Dominate the Influenza Diagnostics End-User Market in 2016
Figure 19 Geographic Snapshot: Asia-Pacific to Be the Fastest-Growing Region During the Forecast Period
Figure 20 Europe: Market Snapshot
Figure 21 North America: Influenza Diagnostics Market Snapshot
Figure 22 Companies Majorly Pursued the Strategy of Product Launches and Approvals Between 2014 and 2016
Figure 23 Battle for Market Share: Product Launches and Approvals Was the Key Strategy Adopted By Market Players in Influenza Diagnostics Market Between 2014 and 2016
Figure 24 Geographic Revenue Mix of the Top 5 Market Players (2015)
Figure 25 F. Hoffmann-La Roche AG: Company Snapshot (2015)
Figure 26 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 27 Thermo Fisher Scientific Inc.: Company Snapshot (2015)
Figure 28 Alere Inc.: Company Snapshot (2015)
Figure 29 Diasorin S.P.A.: Company Snapshot (2015)
Figure 30 Quidel Corporation: Company Snapshot (2015)
Figure 31 Meridian Bioscience, Inc.: Company Snapshot (2015)
Figure 32 Analytik Jena AG: Company Snapshot (2014)
Figure 33 Luminex Corporation: Company Snapshot (2015)

  • Infectious Diseases 2021: Supplier Shares and Market Segment Forecasts by Test--A Rapidly Growing and Challenging Market Facing Suppliers--Technological Breakthroughs, Emerging Tests, Competitive Intelligence
    Published: 14-Sep-2017        Price: US 24500 Onwards        Pages: 1900
    Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. LeadingMarketResearch.com's new report is a seven-countrystrategic analysis of major business opportunities emerging in the infectious disease testing market during the nextfive years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; reviews current and emerging assays; analyzes potential ......
  • Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 19500 Onwards        Pages: 775
    Complete report $19,500. DataPack (test volumes, sales forecasts, supplier shares) $12,500. The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new seven-country study from LeadingMarketResearchcontains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in......
  • Europe Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 11800 Onwards        Pages: 700
    Complete report $11,800. DataPack (test volumes, sales forecasts, supplier shares) $7,700. The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new five-country study from LeadingMarketResearchcontains 700 pages, 54 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infe......
  • France Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 4350 Onwards        Pages: 615
    Complete report $4,350. DataPack (test volumes, sales forecasts, supplier shares) $2,800. The reportis available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new study from LeadingMarketResearchcontains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular......
  • Germany Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 4350 Onwards        Pages: 615
    Complete report $4,350. DataPack (test volumes, sales forecasts, supplier shares) $2,800. The reportis available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new study from LeadingMarketResearchcontains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular......
  • Italy Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 4350 Onwards        Pages: 610
    Complete report $4,350. DataPack (test volumes, sales forecasts, supplier shares) $2,800. The reportis available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new study from LeadingMarketResearchcontains 610 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular......
  • Japan Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 5400 Onwards        Pages: 620
    Complete report $4,350. DataPack (test volumes, sales forecasts, supplier shares) $2,800. The reportis available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new study from LeadingMarketResearchcontains 620 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular......
  • Spain Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 4350 Onwards        Pages: 610
    Complete report $4,350. DataPack (test volumes, sales forecasts, supplier shares) $2,800. The reportis available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new study from LeadingMarketResearchcontains 610 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular......
  • UK Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 4350 Onwards        Pages: 615
    Complete report $4,350. DataPack (test volumes, sales forecasts, supplier shares) $2,800. The reportis available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new study from LeadingMarketResearchcontains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs